chemie.pr-Bankkaufmann - News
European Medicines Agency (EMEA) Approves Relistor(TM) The First-in-Class Treatment of Opioid-Induced Constipation (OIC) in Advanced-Illness Patients
European Medicines Agency (EMEA) Approves Relistor(TM) The First-in-Class Treatment of Opioid-Induced Constipation (OIC) in Advanced-Illness Patients
07.07.2008 20:40:05
Wyeth Pharmaceuticals: Maidenhead, England (ots/PRNewswire) - - First-in-Class Treatment set to Provide a New and Important Targeted Treatment for Distressing and near Universal Side Effect in Patients Receiving Opioids for Pain Relief as Part of Palliative ...
Lesen Sie hier weiter... |
Drucken |
PDF
Ähnliche Artikel
- Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
- Movetis Files RESOLOR(R) With EMEA for the Indication of Chronic Constipation
- INTELENCE(TM) (Etravirine) Receives Marketing Authorisation in the European Union for HIV Combination Therapy
- Astellas' Mycamine(R) (micafungin) Licensed for Use in Europe to Treat Serious Fungal Infections
- European Approval for Roche's Pegasys Personalises Treatment for a Subgroup of Hepatitis C Patients: Chance for Cure With Only Four Months of Treatment
- European Commission Approval of New Indication for Roche's Pegasys(R) (peginterferon alfa-2a) Offers Hepatitis C Patients a Second Chance for a Cure
- Inovelon(R) a New Treatment for Lennox-Gastaut Syndrome Reduces Drop Attacks by Over 40%
- New Published Data Support Safety and Efficacy of RESOLOR(R) for Treatment of Chronic Constipation
- PREZISTA(R) (darunavir) Receives Expanded Marketing Authorisation in the European Union for Treatment-Experienced Adults With HIV-1
- Xeloda (capecitabine) Shown to be Superior to IV 5-FU in Advanced Stomach and Oesophageal Cancer
ots.at: das APA-OTS-Portal für multimediale Presseaussendungen
European Medicines Agency (EMEA) Approves Relistor(TM) The First-in-Class Treatment of Opioid-Induced Constipation (OIC) in Advanced-Illness Patients
Presseportal: Branchenansicht - Chemie
European Medicines Agency (EMEA) Approves Relistor(TM) The First-in-Class Treatment of Opioid-Induced Constipation (OIC) in Advanced-Illness Patients
Pressemitteilungen und Pressemeldungen vom 07.07.2008 | PresseEcho.de
European Medicines Agency (EMEA) Approves Relistor(TM) The First-in-Class Treatment of Opioid-Induced Constipation (OIC) in Advanced-Illness Patients
EUROPEAN MEDICINES AGENCY EMEA APPROVES RELISTORTM THE FIRST-IN-CLASS ...
European Medicines Agency (EMEA) Approves Relistor(TM) The First-in-Class Treatment of Opioid-Induced Constipation (OIC) in Advanced-Illness Patients